MR
Martin Rudolf Wartmann
About Martin Rudolf Wartmann
Data last updated:
Martin Rudolf Wartmann is a Director at Geistlich Pharma India Private Limited (since 2025). The company operates in Trading. Geistlich Pharma India Private Limited reported revenue of ₹15.83 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Geistlich Pharma India Private Limited U74999DL2015FTC287895 | Director | 19 Sep 2025 | 2015 | ₹15.83 Cr (FY 2025) | Active |
Board colleagues of Martin Rudolf Wartmann
| Name | DIN | Company | Designation |
|---|---|---|---|
| Jurg Reto Roth | 08037506 | Geistlich Pharma India Private Limited | Director |
| Matthias Peter Hermann Dunkel | 08936151 | Geistlich Pharma India Private Limited | Director |
| Prakash Virendra Kotak | 02284814 | Geistlich Pharma India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Martin Rudolf Wartmann
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Martin Rudolf Wartmann
Martin Rudolf Wartmann currently holds 1 directorship: Geistlich Pharma India Private Limited (Director, since 19 Sep 2025, revenue ₹15.83 Cr (FY 2025)).
Martin Rudolf Wartmann was first appointed on 19 Sep 2025 as Director at Geistlich Pharma India Private Limited.
The current boards of Martin Rudolf Wartmann's companies include Jurg Reto Roth (Geistlich Pharma India Private Limited), Matthias Peter Hermann Dunkel (Geistlich Pharma India Private Limited), Prakash Virendra Kotak (Geistlich Pharma India Private Limited).